Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine PS DDS paired-eye sham-controlled study in geographic atrophy due to AMD
2008-001487-37Phase 2Completed
- Sponsor
- Allergan
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of brimonidine in age-related macular degeneration (AMD) (3 arms), sponsored by Allergan. Primary endpoint: Safety of Brimo PS DDS Applicator System. Started Jul 2008; status: completed.
02
Drugs
brimonidine
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2008-001487-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001487-37.